
Quality RO (QRIL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
195.9M
Total Liabilities
80.8M
Shareholders Equity
115.1M
Debt to Equity
0.70
Cash Flow Metrics
Revenue & Profitability Trend
Quality RO Income Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue | 160.0M | 132.2M | 55.2M | 9.7M |
Cost of Goods Sold | 102.5M | 91.4M | 31.6M | 4.2M |
Gross Profit | 57.6M | 40.9M | 23.6M | 5.5M |
Gross Margin % | 36.0% | 30.9% | 42.7% | 56.8% |
Operating Expenses | ||||
Research & Development | - | - | - | - |
Selling, General & Administrative | - | 1.8M | 424.0K | 587.0K |
Other Operating Expenses | 16.2M | 13.8M | 13.9M | 1.8M |
Total Operating Expenses | 16.2M | 15.6M | 14.3M | 2.4M |
Operating Income | 27.3M | 20.5M | 404.0K | 1.0M |
Operating Margin % | 17.1% | 15.5% | 0.7% | 10.4% |
Non-Operating Items | ||||
Interest Income | - | 1.3M | 643.0K | 88.0K |
Interest Expense | 4.4M | 1.5M | 1.1M | 170.0K |
Other Non-Operating Income | - | - | - | - |
Pre-tax Income | 23.2M | 20.4M | -458.0K | 1.0M |
Income Tax | 5.9M | 4.8M | -273.0K | -450.0K |
Effective Tax Rate % | 25.6% | 23.6% | 0.0% | -43.3% |
Net Income | 17.3M | 15.6M | -185.0K | 1.5M |
Net Margin % | 10.8% | 11.8% | -0.3% | 15.3% |
Key Metrics | ||||
EBITDA | 32.3M | 26.9M | 7.5M | 2.7M |
EPS (Basic) | - | ₹6.11 | ₹-0.09 | ₹0.98 |
EPS (Diluted) | - | ₹6.11 | ₹-0.09 | ₹0.98 |
Basic Shares Outstanding | - | 2548282 | 1993000 | 1520408 |
Diluted Shares Outstanding | - | 2548282 | 1993000 | 1520408 |
Income Statement Trend
Quality RO Balance Sheet From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 11.7M | 12.0M | 4.7M | 19.3M |
Short-term Investments | - | 5.0M | 41.1M | - |
Accounts Receivable | 34.7M | 32.0M | 16.3M | 3.8M |
Inventory | 84.2M | 47.2M | 4.2M | 5.6M |
Other Current Assets | 360.0K | -1.0K | -1.0K | 6.0M |
Total Current Assets | 144.1M | 131.5M | 88.4M | 34.8M |
Non-Current Assets | ||||
Property, Plant & Equipment | - | 1.0K | 70.0K | 70.0K |
Goodwill | - | - | 0 | 0 |
Intangible Assets | - | - | - | - |
Long-term Investments | - | - | - | - |
Other Non-Current Assets | - | 1.0K | 608.0K | 609.0K |
Total Non-Current Assets | 51.8M | 22.4M | 23.3M | 29.7M |
Total Assets | 195.9M | 153.9M | 111.7M | 64.5M |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | 9.0M | 25.2M | 4.8M | 1.3M |
Short-term Debt | 16.7M | 9.9M | 12.0M | 8.7M |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | 3.0M | 6.5M | -1.0K | 514.0K |
Total Current Liabilities | 33.5M | 45.2M | 17.4M | 10.6M |
Non-Current Liabilities | ||||
Long-term Debt | 47.2M | 10.8M | 12.1M | 14.8M |
Deferred Tax Liabilities | - | - | 0 | 0 |
Other Non-Current Liabilities | -1.0K | 1.0K | 1.0K | -1.0K |
Total Non-Current Liabilities | 47.2M | 10.8M | 12.1M | 14.8M |
Total Liabilities | 80.8M | 56.1M | 29.4M | 25.4M |
Equity | ||||
Common Stock | 25.5M | 25.5M | 25.5M | 19.3M |
Retained Earnings | - | 16.9M | 1.3M | 1.5M |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | 115.1M | 97.9M | 82.3M | 39.1M |
Key Metrics | ||||
Total Debt | 63.9M | 20.7M | 24.1M | 23.4M |
Working Capital | 110.6M | 86.3M | 71.0M | 24.2M |
Balance Sheet Composition
Quality RO Cash Flow Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Operating Activities | ||||
Net Income | 23.2M | 20.4M | -458.0K | 1.0M |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | - | - | - | - |
Working Capital Changes | -51.1M | -65.7M | -27.5M | -15.0M |
Operating Cash Flow | -23.8M | -44.0M | -27.1M | -13.7M |
Investing Activities | ||||
Capital Expenditures | -73.0K | -4.8M | 0 | -29.9M |
Acquisitions | - | - | - | - |
Investment Purchases | - | 0 | -41.1M | - |
Investment Sales | - | 36.1M | 722.0K | 88.0K |
Investing Cash Flow | -73.0K | 31.4M | -39.7M | -30.3M |
Financing Activities | ||||
Share Repurchases | - | - | - | - |
Dividends Paid | - | - | - | - |
Debt Issuance | - | - | 632.0K | - |
Debt Repayment | - | -3.4M | - | - |
Financing Cash Flow | 1.1K | -3.4M | 81.2M | 57.8M |
Free Cash Flow | -39.4M | -24.0M | -16.7M | -40.9M |
Net Change in Cash | -23.8M | -16.0M | 14.5M | 13.8M |
Cash Flow Trend
Quality RO Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
19.87
Price to Book
3.01
Price to Sales
2.14
Profitability Ratios
Profit Margin
10.79%
Operating Margin
30.84%
Return on Equity
16.28%
Return on Assets
10.70%
Financial Health
Current Ratio
4.30
Debt to Equity
55.49
Beta
0.39
Per Share Data
EPS (TTM)
₹6.77
Book Value per Share
₹44.64
Revenue per Share
₹62.73
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
qril | 343.0M | 19.87 | 3.01 | 16.28% | 10.79% | 55.49 |
Ion Exchange (India | 50.5B | 22.79 | 4.14 | 17.18% | 7.69% | 0.27 |
Banka Bioloo | 949.5M | 57.14 | 2.98 | -28.23% | -17.55% | 109.95 |
Filtra Consultants | 778.4M | 24.72 | 3.22 | 12.17% | 3.35% | 0.00 |
Larsen & Toubro | 5.2T | 32.36 | 5.26 | 13.03% | 5.90% | 114.74 |
Hindustan | 3.4T | 36.36 | 8.70 | 26.09% | 27.00% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.